Journal article
Hypoalbuminemia in Patients With Multiple Myeloma
Archives of internal medicine (1960), Vol.150(3), pp.605-610
03/01/1990
DOI: 10.1001/archinte.1990.00390150095018
PMID: 2310279
Abstract
• Clinical data of 65 patients with myeloma were analyzed to identify factors associated with hypoalbuminemia. The serum albumin level was not affected by patient age and gender, type of myeloma, and the occurrence of Bence Jones protein, lytic bone lesions, or hypercalcemia, and it was not related to changes in body weight or in liver and renal function. The albumin level, lower in patients with proteinuria, was unrelated to severity of proteinuria. Albumin level correlated significantly with the monoclonal IgG level, hemoglobin concentration, clinical stage of disease, and estimated body tumor burden. Further analysis indicated the disease stage or the tumor burden as the dominant factor in determining albumin level. An albumin level of 29.0 g/L or less identified unequivocally advanced disease. Practically all patients with stage III myeloma had a serum albumin level of 37.0 g/L or less. Thus, hypoalbuminemia is primarily related to the extent of myeloma proliferation and is therefore of diagnostic and prognostic importance.(Arch Intern Med. 1990;150:605-610)
Details
- Title: Subtitle
- Hypoalbuminemia in Patients With Multiple Myeloma
- Creators
- Yi-Hsiang ChenMargarida C Magalhaes
- Resource Type
- Journal article
- Publication Details
- Archives of internal medicine (1960), Vol.150(3), pp.605-610
- DOI
- 10.1001/archinte.1990.00390150095018
- PMID
- 2310279
- NLM abbreviation
- Arch Intern Med
- ISSN
- 0003-9926
- eISSN
- 1538-3679
- Publisher
- American Medical Association
- Language
- English
- Date published
- 03/01/1990
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984094492302771
Metrics
12 Record Views